Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Teams with Washington University, Denver Health for Pathogen ID Trials

NEW YORK (GenomeWeb News) – Accelr8 Technology has established collaborations with a research institute and a hospital administration agency to conduct pre-clinical studies aimed at testing its clinical pathogen detection platform, the company said today.
Under the collaboration, Accelr8 will work with Washington University in St. Louis and the Denver Health and Hospital Authority to identify antibiotic resistance mechanisms using the firm’s BACcel system, and will target drug-resistant bacteria including methicillin-resistant Staphylococcus aureus, Pseudomonas, Acinetobacter, Klebsiella, E. coli, and other microbial pathogens that can cause hospital-acquired infections.
The research partners will provide “independent third-party assessments” of the BACcel tests, the company said.
“This plan will give us direct feedback from actual field experience as we integrate each additional test or engineering advance into the system,” Accelr8’s President David Howson said in a statement.
The initial phase of the collaborations will replicate previous studies on Accelr8’s rapid MRSA identification method. When these programs are completed, Accelr8 plans to extend these studies to include additional tests for bacteria and drug resistance.
The company said it already has used its methods in studies aimed at identifying other pathogens that are more difficult to identify and more deadly than MRSA.
Howson said the “relentless advance of antibiotic resistance will to some extent counterbalance improvements in preventive practices,” and that research programs such as Accelr8’s with Denver Health and Washington University “will ultimately prove the unique value of rapid, disease-directed diagnostics in reversing this deadly trend.”

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.